XLV:ARCA-SPDR Select Sector Fund - Health Care

ETF | Health | NYSE Arca

Last Closing Price

USD 87.25


+0.43 (+0.50)%

Market Cap

USD 17.56B



Yahoo Analyst Target


STA Analyst Target

Yahoo Analyst Rating


STA Analyst Rating


STA Verdict



The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Inception Date: 16/12/1998

Primary Benchmark: S&P Health Care Select Sector TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.15%

Management Expense Ratio: 0.14 %

Unadjusted Closing Price

Adjusted Closing Price



Top Sectors


Top Regions


Share Volume

Relative Performance (Total Returns)

Relative Returns (From:    To: 2018-01-16 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
VHT Vanguard Health Care 0.10 %

+0.25 (+0.15%)

USD 7.51B
XBI SPDR Series Trust S&P Biotech 0.35 %

-2.78 (-3.10%)

USD 4.61B
IYH iShares U.S. Healthcare 0.44 %

+0.62 (+0.34%)

USD 2.04B
IXJ iShares Global Healthcare 0.48 %

+0.06 (+0.05%)

USD 1.70B
IHI iShares U.S. Medical Devices 0.44 %

-0.58 (-0.32%)

USD 1.58B
FBT First Trust Amex Biotech Index.. 0.56 %

-2.94 (-2.22%)

USD 1.28B
FXH First Trust Health Care AlphaD.. 0.62 %

-0.34 (-0.46%)

USD 1.04B
HQH Tekla Healthcare Investors 0.00 %

-0.10 (-0.42%)

USD 0.97B
FHLC Fidelity MSCI Health Care Inde.. 0.08 %

+0.09 (+0.21%)

USD 0.97B
THQ Tekla Healthcare Opportunies F.. 0.00 %

-0.03 (-0.17%)

USD 0.78B

ETFs Containing XLV

CURE Direxion Daily Healthcare.. 52.28 % 0.95 %

+0.86 (+-0.06%)

USD 0.17B
FUT:CA First Asset U.S. Tactical.. 10.78 % 0.78 %

+0.11 (+-0.06%)

CAD 7.34M
EQL ALPS Equal Sector Weight 9.55 % 0.15 %

-0.20 (-0.06%)

USD 0.17B
DWAT Arrow DWA Tactical ETF 9.14 % 1.40 %

+0.07 (+-0.06%)

USD 8.56M
WBIR WBI 5.21 % 1.25 %

-0.02 (-0.06%)


Market Performance

  Market Performance vs.
Industry/Classification (Health)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Capital Gain 5.53% 89% B+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.53% 89% B+ 80% B-
Trailing 12 Months  
Capital Gain 23.03% 57% F 75% C
Dividend Return 1.72% 73% C 24% F
Total Return 24.74% 61% D- 73% C
Trailing 5 Years  
Capital Gain 109.38% 55% F 84% B
Dividend Return 12.29% 80% B- 37% F
Total Return 121.67% 65% D 84% B
Average Annual (5 Year Horizon)  
Capital Gain 13.05% 64% D 82% B-
Dividend Return 14.68% 71% C- 81% B-
Total Return 1.62% 75% C 31% F
Risk Return Profile  
Volatility (Standard Deviation) 12.38% 71% C- 60% D-
Risk Adjusted Return 118.56% 93% A 87% B+
Market Capitalization 13.53B 100% A+ 90% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike